This proposal seeks to assess the impact of 24 weeks of metformin on non-calcified plaques
and calcified plaques assessed by coronary CT angiography, and on whether these changes can
be explained by metformin-induced phenotypic and secretory changes of monocytes.
Phase:
Phase 2
Details
Lead Sponsor:
University of Hawaii
Collaborator:
National Institute of General Medical Sciences (NIGMS)